Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cipla
Boehringer Ingelheim
Healthtrust
Covington
Chinese Patent Office
McKinsey
Merck
Moodys

Generated: January 23, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021732

« Back to Dashboard

NDA 021732 describes VANTAS, which is a drug marketed by Endo Pharm and is included in one NDA. It is available from one supplier. Additional details are available on the VANTAS profile page.

The generic ingredient in VANTAS is histrelin acetate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the histrelin acetate profile page.
Summary for 021732
Tradename:VANTAS
Applicant:Endo Pharm
Ingredient:histrelin acetate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021732
Suppliers and Packaging for NDA: 021732
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VANTAS histrelin acetate IMPLANT;SUBCUTANEOUS 021732 NDA Endo Pharmaceuticals Solutions Inc. 67979-500 67979-500-01 1 VIAL, GLASS in 1 CARTON (67979-500-01) > 1 IMPLANT in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:IMPLANT;SUBCUTANEOUSStrength50MG
Approval Date:Oct 12, 2004TE:RLD:Yes

Expired US Patents for NDA 021732

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Pharm VANTAS histrelin acetate IMPLANT;SUBCUTANEOUS 021732-001 Oct 12, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharm VANTAS histrelin acetate IMPLANT;SUBCUTANEOUS 021732-001 Oct 12, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Teva
Merck
Express Scripts
Cantor Fitzgerald
Colorcon
Dow
Argus Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.